Xeltis raised €27M in a Series B round in Dec 2014. The company is based in Zurich, Switzerland. Investors in the round: Life Sciences Partners, VI Partners. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
